-
Mashup Score: 49
By Jana Sawyer, Taylor Elliott & 4 more. The acute toxicities that occur from conditioning chemotherapy can impact the peri-transplant period and have substantial implications on patients’ tolerability and outcomes, irrespective of the treatment of their disease.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 29
By Allison C. Y. Tso, Sanchalika Acharyya & 6 more. Real-world data on the outcome of Asian patients with secondary hemophagocytic lymphohistiocytosis (HLH), especially on dengue-associated HLH, are limited to small case series.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 12Risks and benefits of cannabis as a pain control modality in patients with sickle cell disease | Published in Clinical Hematology International - 12 day(s) ago
By Jeremy W. Jacobs, Brian D. Adkins & 3 more. Opioids have historically been, and continue to be, the mainstay for managing pain in patients with SCD.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 60
By M Shahzad Rauf, Irfan Maghfoor & 6 more. Our study suggests that in patients with primary refractory DLBCL without initial progressive disease after frontline R-CHOP, the depth of response to SC before HDC–ASCT is predictive of relapse.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 88Outpatient CAR T-Cell Therapy as Standard of Care: Current Perspectives and Considerations | Published in Clinical Hematology International - 19 day(s) ago
By Katie Gatwood, Zahra Mahmoudjafari & 6 more. This review provides a summary of currently published experiences, as well as expert opinion regarding implementation of an outpatient CAR-T program.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 38Transfusion Support in Hematopoietic Stem Cell Transplantation: A Contemporary Narrative Review | Published in Clinical Hematology International - 20 day(s) ago
By Brian D. Adkins, Jeremy W. Jacobs & 3 more. Herein, we detail contemporary blood transfusion and transfusion medicine practices for patients undergoing HSCT.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 81Outpatient CAR T-Cell Therapy as Standard of Care: Current Perspectives and Considerations | Published in Clinical Hematology International - 22 day(s) ago
By Katie Gatwood, Zahra Mahmoudjafari & 6 more. This review provides a summary of currently published experiences, as well as expert opinion regarding implementation of an outpatient CAR-T program.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 77Outpatient CAR T-Cell Therapy as Standard of Care: Current Perspectives and Considerations | Published in Clinical Hematology International - 22 day(s) ago
By Katie Gatwood, Zahra Mahmoudjafari & 6 more. This review provides a summary of currently published experiences, as well as expert opinion regarding implementation of an outpatient CAR-T program.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 58
By Jana Sawyer, Taylor Elliott & 4 more. The acute toxicities that occur from conditioning chemotherapy can impact the peri-transplant period and have substantial implications on patients’ tolerability and outcomes, irrespective of the treatment of their disease.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 23
By Tristan Knight E, Olalekan Oluwole & 1 more. We have therefore developed a relevant summary of the currently available literature pertaining to the use of CD19-directed CAR-T cell therapies in pediatric patients.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
«Prevention and management of acute toxicities from conditioning regimens during HSCT» published in Clin Hematol Int, the official peer-reviewed academic open access journal of @TheIACH - No submission fees, page charges or other hidden costs https://t.co/YllNLkhu97